2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00600340
Recruitment Status : Completed
First Posted : January 25, 2008
Last Update Posted : February 18, 2016
Information provided by (Responsible Party):
Central European Cooperative Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2015
  Actual Study Completion Date : November 2015
Publications automatically indexed to this study by Identifier (NCT Number):